Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases-Reference-Cited by-同舟云学术

Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases

Published:2022-06-01 Issue:6 Volume:23 Page:2049-2055
ISSN:2476-762X
Container-title:Asian Pacific Journal of Cancer Prevention
language:en
Short-container-title:Asian Pac J Cancer Prev

Author:

Poparn Hansamon,Srichumpuang Chonlatis,Sosothikul Darintr,Jantarabenjakul Watsamon,Lauhasurayotin Supanun,Techavichit Piti,Chiangthong Kanhatai,Poovorawan Yong

Publisher

EpiSmart Science Vector Ltd

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Link

http://journal.waocp.org/article_90158_d41d8cd98f00b204e9800998ecf8427e.pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer;EJC Paediatric Oncology;2024-12

2. The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria–Tetanus–Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity;Vaccines;2024-09-09

3. COVID‐19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T‐cells;International Journal of Cancer;2024-07-15

4. Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency;Frontiers in Immunology;2023-07-27

5. Vaccinations in children with hematologic malignancies and those receiving hematopoietic stem cell transplants or cellular therapies;Transplant Infectious Disease;2023-07-12